Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To investigate the bio-effects of high single-dose radiation on xenografts of Lewis lung carcinoma.

Methods: Female 8-week-old C57 mice bearing 4-6 mm diameter Lewis lung carcinoma tumors in the hind legs were divided into 3 groups, control group (0 Gy), high single-dose group (12 Gy/one fraction/day) and routine radiation group (22 Gy/11 fraction/15 d). The mean biological effective dose (BED) of both radiation groups was 26.4 Gy. Changes in hypoxia, DNA damage and cell cycle of the tumor cells at 1, 3, 8, 15 and 21 d after first irradiation was assessed by immunofluorescence and flow-cytometry and the tumor growth curve was also made.

Results: Compared to the fractionated treatment, the tumor growth was delayed after single dose irradiation. The percent of hypoxic cells after single dose radiation was lower than fractioned irradiation at 3, 8, 15 d after first radiation. The foci of gamma-H2AX showed that the single dose caused heavier DNA damages than fractioned irradiation at 1, 3 d after first radiation. The decline of G0/G1 percentage and increase of G2/M percentage of cells was found in both radiation schedules, but the G2/M percentage after single dose radiation was higher.

Conclusion: In the C57 mice bearing Lewis lung carcinoma, the high single-dose regimen inhibits the tumor growth more than fractioned irradiation. We hypothesized that conversion of high single-dose to BED using the LQ formalism under estimated the in vivo effect of hypofractionated radiation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

high single-dose
20
lewis lung
16
single dose
16
tumor growth
12
fractioned irradiation
12
radiation
10
bio-effects high
8
single-dose radiation
8
radiation xenografts
8
xenografts lewis
8

Similar Publications

Muscle-invasive bladder cancer (MIBC) with cardiac metastasis typically carries a very poor prognosis. A Black woman in her 70s developed high-grade urothelial carcinoma with squamous differentiation invading the bladder muscle. Despite chemotherapy, radiation, and nephrostomy, the disease progressed.

View Article and Find Full Text PDF

Early postoperative seizures, defined as occurring within 7 days after surgery, are a significant complication that occurs following neurosurgical procedures involving cerebral manipulation. As a result, short-term antiseizure medication is typically administered in Japan despite the lack of consensus regarding its prophylactic use. Perampanel hydrate, an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, was recently introduced in an intravenous formulation in Japan, providing new potential for early postoperative seizures prevention during the perioperative period.

View Article and Find Full Text PDF

[Effect of Kamishoyosan on Primary Dysmenorrhea Pain].

Yakugaku Zasshi

September 2025

Kampo Research Laboratories, Pharmaceutical Company, Kracie, Ltd.

Dysmenorrhea refers to pathological symptoms that occur in association with menstruation during the menstrual period. Treatment options for dysmenorrhea include nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose estrogen-progestin combination pills. However, some patients do not respond to these treatments, and long-term use can lead to adverse reactions, raising additional problems.

View Article and Find Full Text PDF

Background: The practice of systemic antibiotic prophylaxis to prevent surgical site infection (SSI) in breast surgery remains debated. The aim of this review is to provide a comprehensive overview of the literature evaluating the current evidence on the efficacy of antibiotic prophylaxis in nononcologic breast surgery, including risk-reducing mastectomy, gender-affirming mastectomy, augmentation, and reduction.

Methods: A literature search of PubMed and Cochrane databases of 1990-2025 was conducted to identify studies evaluating antibiotic prophylaxis and SSI outcomes in nononcologic breast surgery.

View Article and Find Full Text PDF

Cervical cancer remains a major health burden, particularly in low- and middle-income countries, despite being one of the most preventable cancers. WHO's 90-70-90 targets aim to eliminate cervical cancer globally by 2030. These targets include 90% of girls fully vaccinated with the HPV vaccine by the age of 15 years, 70% of women screened using a high-performance test by the age of 35 years and again by 45 years, and 90% of women with cervical disease receiving appropriate treatment.

View Article and Find Full Text PDF